Li Li
Förmögenhet: 764 M $ per 2026-07-31
Förmögenhet: 764 M $ per 2026-07-31
Li Li is the founder of Shenzhen Hepalink Pharmaceutical Group Co., Ltd., founded in 1998, serving as Chairman.
Current jobs include Chairman & Chief Executive Officer at Hepalink USA, Inc.; Chairman at Shenzhen Techdow Pharmaceutical Co., Ltd.; Chairman at Shenzhen Duopule Industrial Development Co., Ltd. since 2014; Chairman at Shenzhen Arimab Biopharmaceuticals Co., Ltd.; Director at Cytovance Biologics, Inc.; Executive Director at Shenzhen Leren Technology Co. Ltd.; and Executive Director at Urumqi Feilaishi Equity Investment Co. Ltd. Former job includes Non-Executive Director at Hightide Therapeutics, Inc. from 2023 to 2024.
Education includes an undergraduate degree from Sichuan University, conferred in 1987.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-09-30 | 514 349 899 ( 41,24 % ) | 739 M $ | 2026-07-31 | |
HIGHTIDE THERAPEUTICS INC 13,62 % | 2025-06-30 | 77 804 710 ( 13,62 % ) | 26 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. | Grundare | 1998-04-21 |
Shenzhen Leren Technology Co. Ltd.
Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Engages in technology development | Direktör/Styrelseledamot | - |
Urumqi Feilaishi Equity Investment Co. Ltd. | Direktör/Styrelseledamot | - |
Shenzhen Techdow Pharmaceutical Co., Ltd. | Ordförande | - |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Verkställande Direktör | - |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Distributes biochemical products | Ordförande | 2014-01-13 |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Manufactures therapeutic proteins and antibodies products | Direktör/Styrelseledamot | - |
Shenzhen Arimab Biopharmaceuticals Co., Ltd.
Shenzhen Arimab Biopharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in development, production and sales of drugs for the treatment of pneumonia | Ordförande | - |
| Företag | Position | Slut |
|---|---|---|
| HIGHTIDE THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2024-02-02 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 10 |
|---|---|
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Manufactures therapeutic proteins and antibodies products | Health Technology |
Sichuan University
Sichuan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in production of heparin products | Health Technology |
Shenzhen Leren Technology Co. Ltd.
Shenzhen Leren Technology Co. Ltd. Information Technology ServicesTechnology Services Engages in technology development | Technology Services |
Urumqi Feilaishi Equity Investment Co. Ltd. | |
Shenzhen Techdow Pharmaceutical Co., Ltd. | |
Hepalink USA, Inc.
Hepalink USA, Inc. Pharmaceuticals: MajorHealth Technology Develops macromolecule biopharmaceutical products | Health Technology |
Shenzhen Duopule Industrial Development Co., Ltd.
Shenzhen Duopule Industrial Development Co., Ltd. Wholesale DistributorsDistribution Services Distributes biochemical products | Distribution Services |
Hightide Therapeutics, Inc.
Hightide Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of therapies for the treatment of metabolic and digestive diseases | Health Technology |
Shenzhen Arimab Biopharmaceuticals Co., Ltd.
Shenzhen Arimab Biopharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in development, production and sales of drugs for the treatment of pneumonia | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån